TFF Pharmaceuticals, Inc. (TFFP) NASDAQ
$2.21 0.04 (1.84%)
Market Cap: $7.66M
As of 09/12/24 04:00 PM EDT. Market closed.
TFF Pharmaceuticals, Inc. (TFFP)
NASDAQ
$2.21
0.04 (1.84%)
Market Cap: $7.66M
As of 09/12/24 04:00 PM EDT. Market closed.
Add to Portfolio
TFF Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on developing and commercializing drug products based on its patented Thin Film Freezing (TFF) technology platform in the United States and Australia. It intends to focus on the development of inhaled dry powder drugs for the treatment of pulmonary diseases and conditions. The company's lead drug candidates are TFF ... read more
COMPANY PROFILE
Sector
Healthcare
Industry
Biotechnology
CEO
Dr. Harlan F. Weisman
Full Time Employees
19
CEO Compensation (Base)
$550,000
CEO Compensation (Total)
$2.08M
Sector
Healthcare
Industry
Biotechnology
CEO
Dr. Harlan F. Weisman
Full Time Employees
19
CEO Compensation (Base)
$550,000
CEO Compensation (Total)
$2.08M
Address
1751 River Run, TX, Austin, 76107.
PRICE CHART FOR TFF PHARMACEUTICALS, INC.
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$2.14
Previous Close
$2.17
Days Range
$2.02 - $2.37
52 week range
$1.35 - $11
Volume
47,926
Avg. Volume (30 days)
37,969
Market Cap
$7.66M
Dividend Yield
-
P/E
(0.32)
Shares Outstanding
3,466,040
Open
$2.14
Previous Close
$2.17
Days Range
$2.02 - $2.37
52 week range
$1.35 - $11
Volume
47,926
Avg. Volume (30 days)
37,969
Market Cap
$7.66M
Dividend Yield
-
P/E
(0.32)
Shares Outstanding
3,466,040
FINANCIAL STATEMENTS FOR TFF PHARMACEUTICALS, INC.
LOADING...
Open in: 
Open in:
INSIDER TRANSACTIONS FOR TFF PHARMACEUTICALS, INC.
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| CARLSON CAPITAL L P | 10% Owner | Aug 16, 2023 | Sale | $0.39 | 1,000 | 392 | 5,064,000 | Aug 17, 2023, 05:29 PM |
| CARLSON CAPITAL L P | 10% Owner | Aug 15, 2023 | Sale | $0.44 | 215,000 | 94,041 | 5,065,000 | Aug 17, 2023, 05:29 PM |
| Weisman Harlan F | President and CEO | Aug 15, 2023 | Buy | $0.25 | 600,000 | 150,000 | 814,615 | Aug 15, 2023, 08:00 AM |
| ROCAMBOLI STEPHEN | Director | Aug 15, 2023 | Buy | $0.25 | 20,000 | 5,000 | 36,000 | Aug 15, 2023, 08:00 AM |
| Roberts Brandi | Director | Aug 15, 2023 | Buy | $0.25 | 20,000 | 5,000 | 20,000 | Aug 15, 2023, 08:00 AM |
| COLEMAN KIRK ALLEN | Chief Financial Officer | Aug 15, 2023 | Buy | $0.25 | 20,000 | 5,000 | 35,675 | Aug 15, 2023, 08:00 AM |
| MILLS ROBERT S | Director | Aug 15, 2023 | Buy | $0.25 | 40,000 | 10,000 | 55,980 | Aug 15, 2023, 08:00 AM |
| Mikhak Zamaneh | Chief Medical Officer | Aug 15, 2023 | Buy | $0.25 | 120,000 | 30,000 | 135,000 | Aug 15, 2023, 08:00 AM |
| ROCAMBOLI STEPHEN | Director | Mar 10, 2023 | Buy | $0.80 | 13,000 | 10,433 | 16,000 | Mar 13, 2023, 04:22 PM |
| COLEMAN KIRK ALLEN | Chief Financial Officer | Mar 10, 2023 | Buy | $0.79 | 12,000 | 9,457 | 15,675 | Mar 13, 2023, 08:00 AM |
| Weisman Harlan F | President and CEO | Mar 10, 2023 | Buy | $0.88 | 150,000 | 131,835 | 214,615 | Mar 13, 2023, 08:00 AM |
| Mikhak Zamaneh | Chief Medical Officer | Mar 10, 2023 | Buy | $0.82 | 15,000 | 12,300 | 15,000 | Mar 13, 2023, 08:00 AM |
| Weisman Harlan F | President and CEO | Dec 15, 2022 | Buy | $1.06 | 50,000 | 53,000 | 64,615 | Dec 19, 2022, 08:00 AM |
| Fletcher Aaron G.L. | Director | Nov 22, 2022 | Buy | $1.15 | 43,470 | 49,990 | 143,470 | Nov 23, 2022, 07:59 AM |
| THURMAN RANDY H | Director | Sep 29, 2022 | Option Exercise | $2.50 | 40,255 | 100,638 | 40,255 | Sep 30, 2022, 05:20 PM |
| THURMAN RANDY H | Director | Sep 29, 2022 | Sale | $4.29 | 40,255 | 172,694 | 0 | Sep 30, 2022, 05:20 PM |
| Weisman Harlan F | Director | May 18, 2022 | Buy | $5.12 | 2,500 | 12,800 | 10,000 | May 20, 2022, 05:17 PM |
| Weisman Harlan F | Director | May 20, 2022 | Buy | $5.50 | 4,615 | 25,383 | 14,615 | May 20, 2022, 05:17 PM |
| Fletcher Aaron G.L. | Director | May 17, 2022 | Buy | $5.08 | 24,600 | 124,968 | 109,600 | May 17, 2022, 09:57 PM |
| Fletcher Aaron G.L. | Director | May 16, 2022 | Buy | $4.86 | 85,000 | 413,100 | 85,000 | May 17, 2022, 09:57 PM |
| Weisman Harlan F | Director | May 16, 2022 | Buy | $4.74 | 2,500 | 11,850 | 7,500 | May 17, 2022, 09:55 PM |
| COLEMAN KIRK ALLEN | Chief Financial Officer | May 17, 2022 | Buy | $4.83 | 425 | 2,053 | 3,675 | May 17, 2022, 09:53 PM |
| COLEMAN KIRK ALLEN | Chief Financial Officer | May 16, 2022 | Buy | $4.40 | 1,250 | 5,500 | 3,250 | May 17, 2022, 09:53 PM |
| Mattes Glenn R. | President and CEO | May 16, 2022 | Buy | $4.78 | 16,000 | 76,480 | 36,000 | May 17, 2022, 09:51 PM |
| ROCAMBOLI STEPHEN | Director | May 16, 2022 | Buy | $4.54 | 3,000 | 13,620 | 18,722 | May 17, 2022, 09:50 PM |
| Fletcher Aaron G.L. | Director | Apr 04, 2022 | Buy | $6.47 | 542,000 | 3,504,380 | 542,000 | Apr 04, 2022, 06:34 PM |
| Mattes Glenn R. | President and CEO | Sep 16, 2021 | Buy | $7.10 | 10,000 | 71,000 | 20,000 | Sep 16, 2021, 01:35 PM |
| COLEMAN KIRK ALLEN | CFO, Secretary and Treasurer | Sep 16, 2021 | Buy | $7.30 | 1,000 | 7,300 | 2,000 | Sep 16, 2021, 01:33 PM |
| Fairbairn Malcolm | Director | May 19, 2021 | Buy | $8.95 | 10,000 | 89,500 | 10,000 | May 19, 2021, 04:05 PM |
| THURMAN RANDY H | Director | May 18, 2021 | Buy | $9.40 | 1,050 | 9,870 | 1,050 | May 19, 2021, 04:05 PM |
| Lung Therapeutics, Inc. | 10% Owner | Mar 26, 2021 | Sale | $14.00 | 715,000 | 10,010,000 | 2,235,000 | Mar 30, 2021, 11:43 AM |
| ROCAMBOLI STEPHEN | Director | Mar 15, 2021 | Option Exercise | $3.16 | 20,006 | 63,140 | 35,728 | Mar 17, 2021, 08:00 PM |
| ROCAMBOLI STEPHEN | Director | Mar 15, 2021 | Sale | $16.85 | 20,006 | 337,101 | 15,722 | Mar 17, 2021, 08:00 PM |
| Mattes Glenn R. | President and CEO | Mar 15, 2021 | Option Exercise | $2.50 | 50,000 | 125,000 | 60,000 | Mar 17, 2021, 08:00 PM |
| Mattes Glenn R. | President and CEO | Mar 15, 2021 | Sale | $17.04 | 50,000 | 852,000 | 10,000 | Mar 17, 2021, 08:00 PM |
| COLEMAN KIRK ALLEN | CFO, Secretary and Treasurer | Mar 15, 2021 | Option Exercise | $2.50 | 5,000 | 12,500 | 6,000 | Mar 17, 2021, 08:00 PM |
| COLEMAN KIRK ALLEN | CFO, Secretary and Treasurer | Mar 15, 2021 | Sale | $17.05 | 5,000 | 85,250 | 1,000 | Mar 17, 2021, 08:00 PM |
| Mattes Glenn R. | President and CEO | Feb 16, 2021 | Option Exercise | $2.50 | 40,000 | 100,000 | 50,000 | Feb 18, 2021, 07:02 PM |
| Mattes Glenn R. | President and CEO | Feb 16, 2021 | Sale | $16.82 | 40,000 | 672,800 | 10,000 | Feb 18, 2021, 07:02 PM |
| COLEMAN KIRK ALLEN | CFO, Secretary and Treasurer | Feb 16, 2021 | Option Exercise | $2.50 | 5,000 | 12,500 | 6,000 | Feb 18, 2021, 07:02 PM |
| COLEMAN KIRK ALLEN | CFO, Secretary and Treasurer | Feb 16, 2021 | Sale | $16.82 | 5,000 | 84,100 | 1,000 | Feb 18, 2021, 07:02 PM |
| MILLS ROBERT S | Director | Feb 10, 2021 | Option Exercise | $2.50 | 700 | 1,750 | 16,680 | Feb 12, 2021, 04:05 PM |
| MILLS ROBERT S | Director | Feb 10, 2021 | Sale | $20.16 | 700 | 14,112 | 15,980 | Feb 12, 2021, 04:05 PM |
| MILLS ROBERT S | Director | Jan 19, 2021 | Option Exercise | $2.50 | 55,100 | 137,750 | 71,080 | Jan 20, 2021, 08:37 PM |
| MILLS ROBERT S | Director | Jan 20, 2021 | Option Exercise | $2.50 | 12,600 | 31,500 | 28,580 | Jan 20, 2021, 08:37 PM |
| MILLS ROBERT S | Director | Jan 20, 2021 | Sale | $20.20 | 12,600 | 254,520 | 15,980 | Jan 20, 2021, 08:37 PM |
| MILLS ROBERT S | Director | Jan 19, 2021 | Sale | $19.56 | 55,100 | 1,077,756 | 15,980 | Jan 20, 2021, 08:37 PM |
| Mattes Glenn R. | President and CEO | Jan 15, 2021 | Option Exercise | $2.50 | 40,000 | 100,000 | 50,000 | Jan 20, 2021, 08:37 PM |
| Mattes Glenn R. | President and CEO | Jan 15, 2021 | Sale | $17.51 | 40,000 | 700,400 | 10,000 | Jan 20, 2021, 08:37 PM |
| Mattes Glenn R. | President and CEO | Sep 25, 2020 | Sale | $17.00 | 3,000 | 51,000 | 7,000 | Jan 20, 2021, 08:37 PM |
| COLEMAN KIRK ALLEN | CFO, Secretary and Treasurer | Jan 15, 2021 | Option Exercise | $2.50 | 5,000 | 12,500 | 6,000 | Jan 20, 2021, 08:36 PM |
| COLEMAN KIRK ALLEN | CFO, Secretary and Treasurer | Jan 15, 2021 | Sale | $17.50 | 5,000 | 87,500 | 1,000 | Jan 20, 2021, 08:36 PM |
| Mattes Glenn R. | President and CEO | Dec 23, 2020 | Option Exercise | $2.50 | 30,000 | 75,000 | 40,000 | Dec 29, 2020, 04:05 PM |
| Mattes Glenn R. | President and CEO | Dec 23, 2020 | Sale | $15.33 | 30,000 | 459,900 | 10,000 | Dec 29, 2020, 04:05 PM |
| COLEMAN KIRK ALLEN | CFO, Secretary and Treasurer | Dec 23, 2020 | Option Exercise | $2.50 | 10,000 | 25,000 | 11,000 | Dec 29, 2020, 04:05 PM |
| COLEMAN KIRK ALLEN | CFO, Secretary and Treasurer | Dec 23, 2020 | Sale | $15.24 | 10,000 | 152,400 | 1,000 | Dec 29, 2020, 04:05 PM |
| MILLS ROBERT S | Director | Dec 11, 2020 | Option Exercise | $2.50 | 22,794 | 56,985 | 38,774 | Dec 15, 2020, 04:05 PM |
| MILLS ROBERT S | Director | Dec 11, 2020 | Sale | $14.58 | 22,794 | 332,337 | 15,980 | Dec 15, 2020, 04:05 PM |
| WINDSOR JAMES BRIAN | Chief Science Officer | Dec 07, 2020 | Option Exercise | $2.50 | 25,000 | 62,500 | 30,000 | Dec 09, 2020, 04:30 PM |
| WINDSOR JAMES BRIAN | Chief Science Officer | Dec 07, 2020 | Sale | $15.80 | 25,000 | 395,000 | 5,000 | Dec 09, 2020, 04:30 PM |
| Lung Therapeutics, Inc. | 10% Owner | Dec 04, 2020 | Sale | $13.86 | 1,050,000 | 14,548,000 | 3,500,000 | Dec 08, 2020, 04:31 PM |
| Fletcher Aaron G.L. | Director | Nov 24, 2020 | Buy | $15.13 | 5,000 | 75,656 | 100,000 | Nov 24, 2020, 04:05 PM |
| Fairbairn Malcolm | Director | Nov 12, 2020 | Sale | $15.97 | 11,669 | 186,307 | 0 | Nov 13, 2020, 09:01 PM |
| Fairbairn Malcolm | Director | Nov 11, 2020 | Sale | $15.93 | 63,331 | 1,008,926 | 11,669 | Nov 13, 2020, 09:01 PM |
| THURMAN RANDY H | Director | Nov 11, 2020 | Option Exercise | $2.50 | 34,504 | 86,260 | 39,504 | Nov 13, 2020, 09:01 PM |
| THURMAN RANDY H | Director | Nov 11, 2020 | Sale | $15.91 | 34,504 | 548,890 | 5,000 | Nov 13, 2020, 09:01 PM |
| THURMAN RANDY H | Director | Nov 13, 2020 | Sale | $17.17 | 5,000 | 85,865 | 0 | Nov 13, 2020, 09:01 PM |
| ROCAMBOLI STEPHEN | Director | Nov 11, 2020 | Option Exercise | $2.50 | 15,722 | 39,305 | 15,722 | Nov 13, 2020, 09:00 PM |
| ROCAMBOLI STEPHEN | Director | Nov 10, 2020 | Option Exercise | $2.50 | 21,278 | 53,195 | 21,278 | Nov 13, 2020, 09:00 PM |
| ROCAMBOLI STEPHEN | Director | Nov 11, 2020 | Sale | $15.76 | 15,722 | 247,732 | 0 | Nov 13, 2020, 09:00 PM |
| ROCAMBOLI STEPHEN | Director | Nov 10, 2020 | Sale | $15.14 | 21,278 | 322,106 | 0 | Nov 13, 2020, 09:00 PM |
| COLEMAN KIRK ALLEN | CFO, Secretary, and Treasurer | Nov 10, 2020 | Option Exercise | $2.50 | 15,000 | 37,500 | 16,000 | Nov 13, 2020, 09:00 PM |
| COLEMAN KIRK ALLEN | CFO, Secretary, and Treasurer | Nov 10, 2020 | Sale | $15.12 | 15,000 | 226,755 | 1,000 | Nov 13, 2020, 09:00 PM |
| Mattes Glenn R. | President and CEO | Nov 10, 2020 | Option Exercise | $2.50 | 108,830 | 272,075 | 118,830 | Nov 13, 2020, 09:00 PM |
| Mattes Glenn R. | President and CEO | Nov 10, 2020 | Sale | $14.99 | 108,830 | 1,631,906 | 10,000 | Nov 13, 2020, 09:00 PM |
| Fletcher Aaron G.L. | Director | May 26, 2020 | Buy | $5.08 | 20,000 | 101,600 | 95,000 | May 26, 2020, 07:14 PM |
| Fletcher Aaron G.L. | Director | Apr 15, 2020 | Buy | $4.72 | 5,581 | 26,342 | 75,000 | Apr 17, 2020, 03:06 PM |
| Fletcher Aaron G.L. | Director | Apr 06, 2020 | Buy | $4.24 | 6,252 | 26,508 | 69,419 | Apr 06, 2020, 07:28 PM |
| Fletcher Aaron G.L. | Director | Apr 03, 2020 | Buy | $3.97 | 16,748 | 66,490 | 63,167 | Apr 06, 2020, 07:28 PM |
| Fletcher Aaron G.L. | Director | Apr 02, 2020 | Buy | $3.75 | 500 | 1,875 | 46,419 | Apr 06, 2020, 07:28 PM |
| Mattes Glenn R. | President and CEO | Oct 25, 2019 | Buy | $5.00 | 10,000 | 50,000 | 10,000 | Oct 30, 2019, 08:02 PM |
| Mattes Glenn R. | President and CEO | Oct 25, 2019 | Buy | $5.00 | 10,000 | 50,000 | 10,000 | Oct 30, 2019, 08:02 PM |
| WINDSOR JAMES BRIAN | Chief Science Officer | Oct 25, 2019 | Buy | $5.00 | 5,000 | 25,000 | 5,000 | Oct 29, 2019, 08:35 PM |
| Weisman Harlan F | Director | Oct 25, 2019 | Buy | $5.00 | 5,000 | 25,000 | 5,000 | Oct 29, 2019, 08:34 PM |
| THURMAN RANDY H | Director | Oct 25, 2019 | Buy | $5.00 | 5,000 | 25,000 | 5,000 | Oct 29, 2019, 08:32 PM |
| MILLS ROBERT S | Director | Oct 25, 2019 | Buy | $5.00 | 5,000 | 25,000 | 5,000 | Oct 29, 2019, 08:29 PM |
| Mattes Glenn R. | President and CEO | Oct 25, 2019 | Buy | $5.00 | 10,000 | 50,000 | 10,000 | Oct 29, 2019, 08:27 PM |
| Fletcher Aaron G.L. | Director | Oct 25, 2019 | Buy | $5.00 | 2,000 | 10,000 | 2,000 | Oct 29, 2019, 08:26 PM |
| COLEMAN KIRK ALLEN | CFO, Secretary, and Treasurer | Oct 25, 2019 | Buy | $5.00 | 1,000 | 5,000 | 1,000 | Oct 29, 2019, 08:25 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
| Owner | Relationship | Date | Value($) |
| CARLSON CAPITAL L P | 10% Owner | 08/16/2023 | 392 |
| CARLSON CAPITAL L P | 10% Owner | 08/15/2023 | 94,041 |
| Weisman Harlan F | President and CEO | 08/15/2023 | 150,000 |
| ROCAMBOLI STEPHEN | Director | 08/15/2023 | 5,000 |
| Roberts Brandi | Director | 08/15/2023 | 5,000 |
| COLEMAN KIRK ALLEN | Chief Financial Officer | 08/15/2023 | 5,000 |
| MILLS ROBERT S | Director | 08/15/2023 | 10,000 |
| Mikhak Zamaneh | Chief Medical Officer | 08/15/2023 | 30,000 |
| ROCAMBOLI STEPHEN | Director | 03/10/2023 | 10,433 |
| COLEMAN KIRK ALLEN | Chief Financial Officer | 03/10/2023 | 9,457 |
| Weisman Harlan F | President and CEO | 03/10/2023 | 131,835 |
| Mikhak Zamaneh | Chief Medical Officer | 03/10/2023 | 12,300 |
| Weisman Harlan F | President and CEO | 12/15/2022 | 53,000 |
| Fletcher Aaron G.L. | Director | 11/22/2022 | 49,990 |
| THURMAN RANDY H | Director | 09/29/2022 | 100,638 |
| THURMAN RANDY H | Director | 09/29/2022 | 172,694 |
| Weisman Harlan F | Director | 05/18/2022 | 12,800 |
| Weisman Harlan F | Director | 05/20/2022 | 25,383 |
| Fletcher Aaron G.L. | Director | 05/17/2022 | 124,968 |
| Fletcher Aaron G.L. | Director | 05/16/2022 | 413,100 |
| Weisman Harlan F | Director | 05/16/2022 | 11,850 |
| COLEMAN KIRK ALLEN | Chief Financial Officer | 05/17/2022 | 2,053 |
| COLEMAN KIRK ALLEN | Chief Financial Officer | 05/16/2022 | 5,500 |
| Mattes Glenn R. | President and CEO | 05/16/2022 | 76,480 |
| ROCAMBOLI STEPHEN | Director | 05/16/2022 | 13,620 |
| Fletcher Aaron G.L. | Director | 04/04/2022 | 3,504,380 |
| Mattes Glenn R. | President and CEO | 09/16/2021 | 71,000 |
| COLEMAN KIRK ALLEN | CFO, Secretary and Treasurer | 09/16/2021 | 7,300 |
| Fairbairn Malcolm | Director | 05/19/2021 | 89,500 |
| THURMAN RANDY H | Director | 05/18/2021 | 9,870 |
| Lung Therapeutics, Inc. | 10% Owner | 03/26/2021 | 10,010,000 |
| ROCAMBOLI STEPHEN | Director | 03/15/2021 | 63,140 |
| ROCAMBOLI STEPHEN | Director | 03/15/2021 | 337,101 |
| Mattes Glenn R. | President and CEO | 03/15/2021 | 125,000 |
| Mattes Glenn R. | President and CEO | 03/15/2021 | 852,000 |
| COLEMAN KIRK ALLEN | CFO, Secretary and Treasurer | 03/15/2021 | 12,500 |
| COLEMAN KIRK ALLEN | CFO, Secretary and Treasurer | 03/15/2021 | 85,250 |
| Mattes Glenn R. | President and CEO | 02/16/2021 | 100,000 |
| Mattes Glenn R. | President and CEO | 02/16/2021 | 672,800 |
| COLEMAN KIRK ALLEN | CFO, Secretary and Treasurer | 02/16/2021 | 12,500 |
| COLEMAN KIRK ALLEN | CFO, Secretary and Treasurer | 02/16/2021 | 84,100 |
| MILLS ROBERT S | Director | 02/10/2021 | 1,750 |
| MILLS ROBERT S | Director | 02/10/2021 | 14,112 |
| MILLS ROBERT S | Director | 01/19/2021 | 137,750 |
| MILLS ROBERT S | Director | 01/20/2021 | 31,500 |
| MILLS ROBERT S | Director | 01/20/2021 | 254,520 |
| MILLS ROBERT S | Director | 01/19/2021 | 1,077,756 |
| Mattes Glenn R. | President and CEO | 01/15/2021 | 100,000 |
| Mattes Glenn R. | President and CEO | 01/15/2021 | 700,400 |
| Mattes Glenn R. | President and CEO | 09/25/2020 | 51,000 |
| COLEMAN KIRK ALLEN | CFO, Secretary and Treasurer | 01/15/2021 | 12,500 |
| COLEMAN KIRK ALLEN | CFO, Secretary and Treasurer | 01/15/2021 | 87,500 |
| Mattes Glenn R. | President and CEO | 12/23/2020 | 75,000 |
| Mattes Glenn R. | President and CEO | 12/23/2020 | 459,900 |
| COLEMAN KIRK ALLEN | CFO, Secretary and Treasurer | 12/23/2020 | 25,000 |
| COLEMAN KIRK ALLEN | CFO, Secretary and Treasurer | 12/23/2020 | 152,400 |
| MILLS ROBERT S | Director | 12/11/2020 | 56,985 |
| MILLS ROBERT S | Director | 12/11/2020 | 332,337 |
| WINDSOR JAMES BRIAN | Chief Science Officer | 12/07/2020 | 62,500 |
| WINDSOR JAMES BRIAN | Chief Science Officer | 12/07/2020 | 395,000 |
| Lung Therapeutics, Inc. | 10% Owner | 12/04/2020 | 14,548,000 |
| Fletcher Aaron G.L. | Director | 11/24/2020 | 75,656 |
| Fairbairn Malcolm | Director | 11/12/2020 | 186,307 |
| Fairbairn Malcolm | Director | 11/11/2020 | 1,008,926 |
| THURMAN RANDY H | Director | 11/11/2020 | 86,260 |
| THURMAN RANDY H | Director | 11/11/2020 | 548,890 |
| THURMAN RANDY H | Director | 11/13/2020 | 85,865 |
| ROCAMBOLI STEPHEN | Director | 11/11/2020 | 39,305 |
| ROCAMBOLI STEPHEN | Director | 11/10/2020 | 53,195 |
| ROCAMBOLI STEPHEN | Director | 11/11/2020 | 247,732 |
| ROCAMBOLI STEPHEN | Director | 11/10/2020 | 322,106 |
| COLEMAN KIRK ALLEN | CFO, Secretary, and Treasurer | 11/10/2020 | 37,500 |
| COLEMAN KIRK ALLEN | CFO, Secretary, and Treasurer | 11/10/2020 | 226,755 |
| Mattes Glenn R. | President and CEO | 11/10/2020 | 272,075 |
| Mattes Glenn R. | President and CEO | 11/10/2020 | 1,631,906 |
| Fletcher Aaron G.L. | Director | 05/26/2020 | 101,600 |
| Fletcher Aaron G.L. | Director | 04/15/2020 | 26,342 |
| Fletcher Aaron G.L. | Director | 04/06/2020 | 26,508 |
| Fletcher Aaron G.L. | Director | 04/03/2020 | 66,490 |
| Fletcher Aaron G.L. | Director | 04/02/2020 | 1,875 |
| Mattes Glenn R. | President and CEO | 10/25/2019 | 50,000 |
| Mattes Glenn R. | President and CEO | 10/25/2019 | 50,000 |
| WINDSOR JAMES BRIAN | Chief Science Officer | 10/25/2019 | 25,000 |
| Weisman Harlan F | Director | 10/25/2019 | 25,000 |
| THURMAN RANDY H | Director | 10/25/2019 | 25,000 |
| MILLS ROBERT S | Director | 10/25/2019 | 25,000 |
| Mattes Glenn R. | President and CEO | 10/25/2019 | 50,000 |
| Fletcher Aaron G.L. | Director | 10/25/2019 | 10,000 |
| COLEMAN KIRK ALLEN | CFO, Secretary, and Treasurer | 10/25/2019 | 5,000 |
Load More Insider Transactions
FUNDS WITH A POSITION IN TFF PHARMACEUTICALS, INC.
| Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
|---|---|---|---|---|
| GEODE CAPITAL MANAGEMENT, LLC | 21,798 | 0% | 25.69% | Other |
| RENAISSANCE TECHNOLOGIES LLC | 14,777 | 0.00004% | 11.96% | Other |
| BLACKROCK INC. | 7,186 | 0% | -7.86% | Other |
CHANGE IN SHARES OUTSTANDING FOR TFF PHARMACEUTICALS, INC.
STOCK BUYBACKS FOR TFF PHARMACEUTICALS, INC.
Period of Report: 03/31/2024
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
12/31/2020
-87.61%
13Q
09/30/2020
-88.56%
14Q
06/30/2020
-87.48%
15Q
BUYBACK ANNOUNCEMENT(S) FOR TFF PHARMACEUTICALS, INC.
LOADING...